Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Oral Squamous Cell Carcinomas”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00896896
What this trial is testing

Immunoreactivity to Cetuximab in Cancer Patients

Who this might be right for
Colorectal CancerHead and Neck Cancer
Vanderbilt-Ingram Cancer Center 538
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07778368
What this trial is testing

A Multicenter, Prospective, Phase II Study of TROP-2 ADC in Combination With Toripalimab for Resectable Locally Advanced Oral Squamous Cell Carcinoma

Who this might be right for
Oral Squamous Cell Carcinoma (OSCC)
Shanghai East Hospital 20
Testing effectiveness (Phase 2)Study completedNCT00665392
What this trial is testing

Cetuximab and Combination Chemotherapy in Patients With Stage III-IV Resectable Oropharynx Cancer

Who this might be right for
Head and Neck Cancer
GERCOR - Multidisciplinary Oncology Cooperative Group 42
Testing effectiveness (Phase 2)UnknownNCT05658016
What this trial is testing

Phase 2a Study to Evaluate Suppression of Radiotherapy-induced Mucositis by TK112690

Who this might be right for
Mucositis
Tosk, Inc. 24
Not applicableStudy completedNCT00828516
What this trial is testing

Using Traditional Acupuncture in the Management of Cancer Treatment Related Lymphoedema

Who this might be right for
Breast CancerHead and Neck CancerLymphedema
East and North Hertfordshire NHS Trust 56
Not applicableUnknownNCT00173381
What this trial is testing

The Role of Lymphangiogenesis in Head and Neck Cancer Metastasis

Who this might be right for
Oral CancerLaryngeal CancerHypopharyngeal Cancer
National Taiwan University Hospital 100
Testing effectiveness (Phase 2)Study completedNCT00005087
What this trial is testing

Paclitaxel, Cisplatin, and Filgrastim Combined With Radiation Therapy in Treating Patients With Locally Recurrent Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Radiation Therapy Oncology Group 105
Not applicableStudy completedNCT07015333
What this trial is testing

Case Review of Patients With Betel Nut-induced Oral Cancer Treated With Pembrolizumab and Cetuximab

Who this might be right for
Oral Squamous Cell Carcinoma (OSCC)
Commonwealth Healthcare Corporation 31
Not applicableLooking for participantsNCT05837221
What this trial is testing

Microbiome in Head and Neck Squamous Cell Carcinoma

Who this might be right for
Head and Neck CancerLip CancerOral Cancer+1 more
University of Colorado, Denver 60
Testing effectiveness (Phase 2)Study completedNCT00639769
What this trial is testing

Irinotecan and Cisplatin in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Vanderbilt-Ingram Cancer Center 41
Early research (Phase 1)Study completedNCT00404339
What this trial is testing

Vaccine Therapy in Treating Patients With Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Robert Ferris 17
Early research (Phase 1)WithdrawnNCT01332279
What this trial is testing

Everolimus, Erlotinib Hydrochloride, and Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer Previously Treated With Radiation Therapy

Who this might be right for
Recurrent Metastatic Squamous Neck Cancer With Occult PrimaryRecurrent Salivary Gland CancerRecurrent Squamous Cell Carcinoma of the Hypopharynx+8 more
Fox Chase Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00022594
What this trial is testing

Liposomal Lurtotecan in Treating Patients With Metastatic or Locally Recurrent Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
European Organisation for Research and Treatment of Cancer - EORTC 50
Testing effectiveness (Phase 2)Ended earlyNCT05316688
What this trial is testing

A Fluorescent Tumor Marking Agent, Tozuleristide, for Imaging Oral Cavity Squamous Cell Cancer and High-Grade Oral Cavity Dysplasia During Surgery

Who this might be right for
Oral Cavity Squamous Cell CarcinomaStage I Lip and Oral Cavity Cancer AJCC v8Stage II Lip and Oral Cavity Cancer AJCC v8+2 more
University of Washington 8
Not applicableLooking for participantsNCT05872880
What this trial is testing

TPExtreme Induced Chemotherapy Followed by Surgery and Radiotherapy in the Oral Carcinoma.

Who this might be right for
Oral Squamous Cell CarcinomaLocally Advanced Head and Neck Squamous Cell Carcinoma
Xiangya Hospital of Central South University 124
Not applicableEnded earlyNCT01949740
What this trial is testing

Patient Preferences in Making Treatment Decisions in Patients With Stage I-IVA Oropharyngeal Cancer

Who this might be right for
Stage I Squamous Cell Carcinoma of the OropharynxStage II Squamous Cell Carcinoma of the OropharynxStage III Squamous Cell Carcinoma of the Oropharynx+2 more
University of Chicago 37
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06875791
What this trial is testing

Safety and Efficacy Trial of TV5M01 for Radiation-Induced Mucositis in Head and Neck Cancer Patients.

Who this might be right for
Squamous Cell Carcinoma of the Head and NeckOral Mucositis
Fundacion Clinica Valle del Lili 40
Large-scale testing (Phase 3)Study completedNCT00002476
What this trial is testing

Radiation Therapy With or Without Chemotherapy in Treating Patients With Advanced Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Cancer Research UK
Early research (Phase 1)Study completedNCT01588678
What this trial is testing

A Open-Label, Multiple Ascending Dose Study of DS-3078a, an Oral TORC1/2 Kinase Inhibitor, in Subjects With Advanced Solid Tumors or Lymphomas

Who this might be right for
Advanced Solid TumorLymphoma
Daiichi Sankyo 32
Early research (Phase 1)Not Yet RecruitingNCT07741643
What this trial is testing

Study Evaluating the Safety and Feasibility of Panitumumab-IRDye800 and [18F]NOTA-ABY-030 for Targeted Dual-Modality Imaging (TDMI) in Head and Neck Squamous Cell Carcinoma

Who this might be right for
HNSCC,Larynx, Pharynx and Oral CavitySquamous Cell CarcinomaHead and Neck Cancer+1 more
Vanderbilt-Ingram Cancer Center 30
Next Page